Alvotech (ALVO)
13.88
+0.11
(+0.80%)
USD |
NASDAQ |
May 31, 16:00
13.84
-0.04
(-0.25%)
After-Hours: 20:00
Alvotech Cash from Investing (Quarterly): -3.48M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.48M |
December 31, 2023 | -10.46M |
September 30, 2023 | -10.65M |
June 30, 2023 | -11.35M |
March 31, 2023 | -13.88M |
Date | Value |
---|---|
December 31, 2022 | -10.47M |
September 30, 2022 | -11.56M |
June 30, 2022 | -28.31M |
March 31, 2022 | -13.19M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-28.31M
Minimum
Jun 2022
-3.48M
Maximum
Mar 2024
-12.60M
Average
-11.35M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
AbbVie Inc | -9.588B |
Moolec Science SA | -0.1281M |
Teva Pharmaceutical Industries Ltd | 144.00M |
Procaps Group SA | -7.469M |
NeuroMetrix Inc | 0.1383M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -75.40M |
Cash from Financing (Quarterly) | 133.18M |
Free Cash Flow | -338.67M |
Free Cash Flow Per Share (Quarterly) | -0.3256 |
Free Cash Flow to Equity (Quarterly) | -98.00M |
Free Cash Flow to Firm (Quarterly) | 98.02M |
Free Cash Flow Yield | -10.04% |